Cancer Advances
Subscribe:
Featured Episode
Unveiling the Cellular and Immunotherapy Service (CITS)
Inpatient Director of the Cellular and Immunotherapy Service, John Molina, MD, EdM, joins the Cancer Advances podcast to talk about the launching of the Cellular and Immunotherapy Service to manage the growing number of patients receiving cellular therapies like CAR-T and bispecific antibodies. Listen as Dr. Molina share insights on the protocols that help identify and mitigate toxicities early, reducing ICU stays and enhancing patient outcomes with the long-term goal of transitioning more patients to outpatient management where possible.
Play NowAll Cancer Advances Episodes
November 7, 2024
New Genomic Models for Leiomyosarcoma Treatment
Josephine K. Dermawan, MD, PhD, a soft tissue pathologist at Cleveland Clinic, joins the Cancer Advances podcast to discuss the development of novel genomic risk stratification models for soft tissue and uterine leiomyosarcomas. Given the complexity and variety of sarcomas, accurately identifying subtypes is key to effective treatment. Listen as Dr. Dermawan explains the challenges of risk stratification and how genomic profiling enhances our ability to predict tumor behavior, leading to more precise treatment decisions.
Play NowOctober 31, 2024
Exploring the Complexities of Neuroendocrine Tumors and Carcinoid Heart Disease
Chair of the Department of Gastroenterology, Hepatology and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss neuroendocrine tumors and carcinoid heart disease. Listen as Dr. Kim shares her expertise on this rare but increasingly prevalent type of cancer, the complexities of managing carcinoid heart disease, a condition seen in patients with metastatic neuroendocrine tumors, and the benefits of multidisciplinary care in treatment planning.
Play NowOctober 24, 2024
Breaking Down Endocrine Therapy: Tailoring Breast Cancer Treatment for Young Women
Breast Medical Oncologist, Erin Roesch, MD, joins the Cancer Advances podcast to discuss endocrine therapy for breast cancer in young patients. Listen as Dr. Roesch explains the key differences in treatment for premenopausal women, including the use of tamoxifen, ovarian suppression, and aromatase inhibitors.
Play NowOctober 17, 2024
Beyond the Sun: Uncovering the Genetic Risks of Melanoma
Joshua Arbesman, MD, Dermatologist and Director of the Pigmented Lesion Clinic at Cleveland Clinic, joins the Cancer Advances podcast to talk about the genetic risks of melanoma. Listen as Dr. Arbesman delves into the inherited predispositions for melanoma, highlights key findings from his research on identifying high-risk patients and explains how genetic testing can help in early detection and personalized treatment.
Play Now
